1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AAAS CTRPv2 pan-cancer AAC -0.13 0.0008
mRNA AADACL2 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA AAED1 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA AARS CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA ABC13-47656900H15.1 CTRPv2 pan-cancer AAC 0.094 0.006
mRNA ABCD1 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA ABHD14A-ACY1 CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA ABHD17C CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA ABHD2 CTRPv2 pan-cancer AAC 0.1 0.005
mRNA ABI3 CTRPv2 pan-cancer AAC -0.12 0.001
Download CSV